Horizon Pharma Announces FDA Approval of Duexis (Ibuprofen/Famotidine)
Links shared publicly online about this topic.
- 333total visits
Horizon Pharma Announces FDA Approval of Duexis (Ibuprofen/Famotidine)
Duexis (famotidine/ibuprofen) is used for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper GI ulcers. Includes Duexis side effects, interactions and indications.
View full resource at drugs.com
Tags: Gastroenterology, Arthritis, Osteoarthritis, Rheumatoid Arthritis, Pharma, FDA, Ulcer
Most Recently Shared on April 28, 2011 at 6:17 am By:
Horizon Pharma Announces FDA Approval of Duexis (Ibuprofen/Famotidine) - http://bit.ly/kDN1ko
Horizon Pharma Announces FDA Approval of Duexis (Ibuprofen/Famotidine)
drugs.com — “Duexis (famotidine/ibuprofen) is used for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper GI ulcers. Includes Duexis side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 26, 2011 at 7:05 am By:
Drugs and Devices OW OW Health
Horizon Pharma Announces FDA Approval of Duexis (Ibuprofen/Famotidine): NORTHBROOK, IL--(Marketwire - Apr ... http://bit.ly/dFPooD #drug
Advertisement
